This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of clinicaluseissue
{ "resourceType": "ClinicalUseIssue", "id": "example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: example</p><p><b>type</b>: contraindication</p><h3>Contraindications</h3><table><tr><td>-</td><td><b>DiseaseSymptomProcedure</b></td><td><b>Comorbidity</b></td></tr><tr><td>*</td><td><span>Hepatic disease associated with coagulopathy and clinically relevant bleeding risk</span></td><td><span>Hepaticdisease</span></td></tr></table></div>" }, "type": "contraindication", "contraindication": { "diseaseSymptomProcedure": { "coding": [ { "system": "http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure", "code": "Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)" } ], "text": "Hepatic disease associated with coagulopathy and clinically relevant bleeding risk" }, "comorbidity": [ { "coding": [ { "system": "http://ema.europa.eu/example/comorbidity", "code": "Hepaticdisease" } ] } ] } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.